CBS News
CBS News
@CBSNews·7M subscribers·153.5K videos

Dr. Deborah Birx responds to latest study on risks of hydroxycholoquine for COVID-19

Posted

May 22, 2020

Views

33,330

Likes

209

Comments

147

Engagement

1.07%

Search the Record

Indexed

Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.

Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.

Try a name, a topic, or a quoted line

YouTube Description

as posted by the channel

White House coronavirus coordinator Dr. Deborah Birx was asked Friday about results of a new study showing COVID-19 patients got no benefit and suffered some serious side effects from the malaria drug President Trump has pushed as a possible treatment. She noted that many of those patients had other health issues. Watch her remarks.

Guests & Subjects Covered

White HouseDr Deborah BirxPresident Trump

Sentinel Indexing in Progress

Metadata and chapters are available. Claim extraction for this episode is pending.

All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.

Dr. Deborah Birx responds to latest study on risks of hydroxycholoquine for COVID-19 · CBS News · Sentinel